{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:12:21Z","timestamp":1781579541664,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011721","name":"Chronic Kidney Disease Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["462\/27"],"award-info":[{"award-number":["462\/27"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.arcmed.2019.08.004","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T23:45:32Z","timestamp":1567727132000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a\u00a0Diagnostic Panel and Pathogenic Pathways"],"prefix":"10.1016","volume":"50","author":[{"given":"Amir","family":"Taherkhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Nafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Arefi-Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Broumandnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Parvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Mahmoudieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2019.08.004_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcmed.2019.08.004_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jfma.2014.11.002","article-title":"Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment","volume":"114","author":"Lai","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.arcmed.2019.08.004_bib3","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/ndt\/gfh521","article-title":"The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994\u20132000","volume":"19","author":"Rychl\u00edk","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2019.08.004_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","article-title":"Membranous nephropathy and malignancy","volume":"30","author":"Beck","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib5","first-page":"807","article-title":"Pathogenesis of membranous nephropathy: update","volume":"61","author":"Kwatra","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.arcmed.2019.08.004_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcmed.2019.08.004_bib7","series-title":"Comprehensive Clinical Nephrology","first-page":"248","article-title":"Membranous nephropathy","author":"Couser","year":"2010"},{"key":"10.1016\/j.arcmed.2019.08.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","article-title":"Metabolomics in chronic kidney disease","volume":"422","author":"Zhao","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2019.08.004_bib9","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.ki.5000289","article-title":"Renal pathology in idiopathic membranous nephropathy: a new perspective","volume":"69","author":"Troyanov","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2019.08.004_bib10","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1172\/JCI72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2019.08.004_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2019.08.004_bib12","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2019.08.004_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/mrc.4460","article-title":"1H NMR-based metabolomics exploring urinary biomarkers correlated with proteinuria in focal segmental glomerulosclerosis: a pilot study","volume":"54","author":"Kalantari","year":"2016","journal-title":"Magn Reson Chem"},{"key":"10.1016\/j.arcmed.2019.08.004_bib14","doi-asserted-by":"crossref","first-page":"e80830","DOI":"10.1371\/journal.pone.0080830","article-title":"Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography","volume":"8","author":"Kalantari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2019.08.004_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/1354750X.2014.956148","article-title":"Urinary messenger RNA of the receptor activator of NF-kappaB could be used to differentiate between minimal change disease and membranous nephropathy","volume":"19","author":"Liu","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.arcmed.2019.08.004_bib16","first-page":"239","article-title":"Diagnostic urinary proteome profile for immunoglobulin a nephropathy","volume":"9","author":"Samavat","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.arcmed.2019.08.004_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneph.2011.152","article-title":"Metabolomics in the study of kidney diseases","volume":"8","author":"Weiss","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib18","doi-asserted-by":"crossref","first-page":"F909","DOI":"10.1152\/ajprenal.00722.2009","article-title":"A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease","volume":"298","author":"Taylor","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cca.2011.12.014","article-title":"Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF\/MS","volume":"413","author":"Zhao","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2019.08.004_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clinbiochem.2014.07.019","article-title":"UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry","volume":"47","author":"Zhao","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.arcmed.2019.08.004_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.2013.328","article-title":"Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease","volume":"85","author":"Posada-Ayala","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2019.08.004_bib22","doi-asserted-by":"crossref","first-page":"782798","DOI":"10.1155\/2015\/782798","article-title":"Human urine proteomics: Analytical techniques and clinical applications in renal diseases","volume":"2015","author":"Kalantari","year":"2015","journal-title":"Int J Proteomics"},{"key":"10.1016\/j.arcmed.2019.08.004_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/bmm-2017-0081","article-title":"A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy","volume":"11","author":"Kalantari","year":"2017","journal-title":"Biomark Med"},{"key":"10.1016\/j.arcmed.2019.08.004_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chroma.2016.05.058","article-title":"Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography\u2013mass spectrometry","volume":"1453","author":"Lee","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.arcmed.2019.08.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2017.01.001","article-title":"Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics","volume":"100","author":"Marshall","year":"2017","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"10.1016\/j.arcmed.2019.08.004_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00216-006-0687-8","article-title":"Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics","volume":"387","author":"Pan","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.arcmed.2019.08.004_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2369-15-141","article-title":"Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis","volume":"15","author":"Kalantari","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2105-12-400","article-title":"MetaboHunter: an automatic approach for identification of metabolites from 1 H-NMR spectra of complex mixtures","volume":"12","author":"Tulpan","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.arcmed.2019.08.004_bib29","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/pr060265y","article-title":"Susceptibility of human metabolic phenotypes to dietary modulation","volume":"5","author":"Stella","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.arcmed.2019.08.004_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cem.695","article-title":"Orthogonal projections to latent structures (O-PLS)","volume":"16","author":"Trygg","year":"2002","journal-title":"J Chemom"},{"key":"10.1016\/j.arcmed.2019.08.004_bib31","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1021\/pr900668v","article-title":"Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints","volume":"8","author":"Teul","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.arcmed.2019.08.004_bib32","first-page":"4197","article-title":"Network analysis of membranous glomerulonephritis based on metabolomics data","volume":"18","author":"Taherkhani","year":"2018","journal-title":"Molecular Med Rep"},{"key":"10.1016\/j.arcmed.2019.08.004_bib33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s40064-015-1304-0","article-title":"Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC\u2013ESI\u2013MS\/MS","volume":"4","author":"Miyazaki","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.arcmed.2019.08.004_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-015-0890-8","article-title":"Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults","volume":"12","author":"Yu","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.arcmed.2019.08.004_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pathogens3010014","article-title":"Metabolism of cholesterol and bile acids by the gut microbiota","volume":"3","author":"G\u00e9rard","year":"2013","journal-title":"Pathogens"},{"key":"10.1016\/j.arcmed.2019.08.004_bib36","doi-asserted-by":"crossref","first-page":"F821","DOI":"10.1152\/ajprenal.00196.2010","article-title":"Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids","volume":"299","author":"Sieber","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-008-9991-2","article-title":"Up regulation of the GRP-78 and GADD-153 and down regulation of Bcl-2 proteins in primary glomerular diseases: a possible involvement of the ER stress pathway in glomerulonephritis","volume":"324","author":"Markan","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arcmed.2019.08.004_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI110163","article-title":"Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat","volume":"67","author":"Kempson","year":"1981","journal-title":"J Clin Inves"},{"key":"10.1016\/j.arcmed.2019.08.004_bib39","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","article-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure","volume":"20","author":"Eto","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2019.08.004_bib40","series-title":"Nutritional management of renal disease","first-page":"49","article-title":"Uremic toxicity","author":"Chmielewski","year":"2013"},{"key":"10.1016\/j.arcmed.2019.08.004_bib41","article-title":"Microbiome\u2013metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease","volume":"1\u201318","author":"Feng","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2019.08.004_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000186836","article-title":"Pseudouridine excretion in healthy subjects and its accumulation in renal failure","volume":"61","author":"Dz\u00farik","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.arcmed.2019.08.004_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.redox.2017.03.017","article-title":"Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt\/\u03b2-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease","volume":"12","author":"Chen","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000168631","article-title":"Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: evidence for primary sympathetic activation","volume":"13","author":"Rahman","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib45","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1752-0509-6-S1-S14","article-title":"Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum","volume":"6","author":"Gao","year":"2012","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.arcmed.2019.08.004_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.18388\/abp.2008_3103","article-title":"Investigation of a wide spectrum of inherited metabolic disorders by\u02c6 1\u02c6 3C NMR spectroscopy","volume":"55","author":"Bal","year":"2008","journal-title":"Acta Biochim Pol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440919301067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440919301067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:47:04Z","timestamp":1759261624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440919301067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0188440919301067"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.08.004","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a\u00a0Diagnostic Panel and Pathogenic Pathways","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2019.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}